nonsquamous cell carcinoma of uterine cervix
Conditions
Interventions
patients with stage Ib2 or II with diameter of over 2 cm nonsquamous cell carcinoma of uterine cervix
Sponsors
Sankai Gynecology Study Group (SGSG)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: The eligibility requirements for entry into this study included a histologically confirmed diagnosis of nonsquamlous cell carcinoma of uterine cervix and no prior chemotherapytreatment. All patients were required to have a Eastern Cooperative Oncology Group performance status of <3, age 20 to 75 years, and adequate bone marrow function, liver function, and renal function defined by neutrophils > 2,000/mm3, platelets > 100,000/mm3, serum AST and ALT < 100 IU/l, serum ALP < 750 IU/l, serum total bilirubin < 1.5 mg/dl, and serum creatinine < 1.5 mg/dl. All patients were required to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1 fever with over 38.0C 2 infection or WBC>12,000/mm3 3 severe complications 4 neuropathy >Grade 2 5 edema > Grade 2 6 double cancer 7 pleural effusion and ascites for which drainage are necessary. 8 previous chemotherapy by taxane compounds
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety | — |
Countries
Japan
Contacts
Public ContactMuneaki Shimada
Tottori University Department of Obstetrics and Gynecology
Outcome results
None listed